Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirsh

Showing results (571-580 of 2,960) with videos related to

Pageof 296
Sort By:
Hematologic Pathology|January 1, 1989
Laboratory monitoring of oral anticoagulant therapyJ S Ginsberg, J Hirsh
The Journal of Infectious Diseases|September 9, 2006
Chloroquine prevents T lymphocyte suppression induced by anthrax lethal toxinMark I Hirsh, Victoria Cohen
Chest|November 20, 1998
Use of antithrombotic agents during pregnancyJ S Ginsberg, J Hirsh
Chest|November 20, 1998
New antithrombotic agentsJ I Weitz, J Hirsh
Biotechniques|March 1, 1994
A new visible light DNA fluorochrome for confocal microscopyM J Lundell, J Hirsh
The American Journal of Cardiology|January 25, 1991
Heparin as an adjunctive treatment after thrombolytic therapy for acute myocardial infarctionM H Prins, J Hirsh
Chest|October 1, 1992
Antithrombotic therapy. IntroductionJ E Dalen, J Hirsh
Progress in Cardiovascular Diseases|February 8, 2000
The emerging role of low-molecular-weight heparin in cardiovascular medicineJ Hirsh, S M Bates
Molecular & General Genetics : MGG|January 7, 1977
Roller mutants of the nematode Caenorhabditis elegansB J Higgins, D Hirsh
Medicine and Law|January 1, 1985
Theories of liability applied to overcome the unique "identification problem" in DES casesL Schreiber, H L Hirsh
Pageof 296

Showing results (571-580 of 2,960) with videos related to

Sort By:
Pageof 296
Hematologic Pathology|January 1, 1989
Laboratory monitoring of oral anticoagulant therapyJ S Ginsberg, J Hirsh
The Journal of Infectious Diseases|September 9, 2006
Chloroquine prevents T lymphocyte suppression induced by anthrax lethal toxinMark I Hirsh, Victoria Cohen
Chest|November 20, 1998
Use of antithrombotic agents during pregnancyJ S Ginsberg, J Hirsh
Chest|November 20, 1998
New antithrombotic agentsJ I Weitz, J Hirsh
Biotechniques|March 1, 1994
A new visible light DNA fluorochrome for confocal microscopyM J Lundell, J Hirsh
The American Journal of Cardiology|January 25, 1991
Heparin as an adjunctive treatment after thrombolytic therapy for acute myocardial infarctionM H Prins, J Hirsh
Chest|October 1, 1992
Antithrombotic therapy. IntroductionJ E Dalen, J Hirsh
Progress in Cardiovascular Diseases|February 8, 2000
The emerging role of low-molecular-weight heparin in cardiovascular medicineJ Hirsh, S M Bates
Molecular & General Genetics : MGG|January 7, 1977
Roller mutants of the nematode Caenorhabditis elegansB J Higgins, D Hirsh
Medicine and Law|January 1, 1985
Theories of liability applied to overcome the unique "identification problem" in DES casesL Schreiber, H L Hirsh
Pageof 296